Mortality of S. aureus bacteremia and infectious diseases specialist consultation - A study of 521 patients in Germany

Journal of Infection

Volumn 59, Issue 4, 2009, Pages 232-239

  Rieg, Siegbert ^a   Peyerl Hoffmann, Gabriele ^a   de With, Katja ^a   Theilacker, Christian ^a   Wagner, Dirk ^a   Hübner, Johannes ^a   Dettenkofer, Markus ^a   Kaasch, Achim ^b   Seifert, Harald ^b   Schneider, Christian ^a   Kern, Winfried V ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Infectious diseases specialist consultation; INSTINCT; Mortality; Quality of care; Risk factors; Staphylococcus aureus bacteremia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONSULTATION; DISEASE CLASSIFICATION; ENDOCARDITIS; FEMALE; GERMANY; HEALTH CARE QUALITY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; UNIVERSITY HOSPITAL;

AGED; BACTEREMIA; COHORT STUDIES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PROGRAM EVALUATION; REFERRAL AND CONSULTATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 72049090639     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.07.015     Document Type: Article

References (32)

1. Benfield T., Espersen F., Frimodt-Moller N., Jensen A.G., Larsen A.R., Pallesen L.V., et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 13 3 (2007) 257-263
2. Blyth C.C., Darragh H., Whelan A., O'Shea J.P., Beaman M.H., and McCarthy J.S. Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia. Intern Med J 32 5-6 (2002) 224-232
3. Chang F.Y., MacDonald B.B., Peacock Jr. J.E., Musher D.M., Triplett P., Mylotte J.M., et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82 5 (2003) 322-332
4. Collignon P., Nimmo G.R., Gottlieb T., and Gosbell I.B. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 11 4 (2005) 554-561
5. Conterno L.O., Wey S.B., and Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 19 1 (1998) 32-37
6. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., and Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 1 (2003) 53-59
7. Cunney R.J., McNamara E.B., alAnsari N., and Smyth E.G. Community and hospital acquired Staphylococcus aureus septicaemia: 115 cases from a Dublin teaching hospital. J Infect 33 1 (1996) 11-13
8. Fatkenheuer G., Preuss M., Salzberger B., Schmeisser N., Cornely O.A., Wisplinghoff H., et al. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 23 3 (2004) 157-162
9. Fowler Jr. V.G., Miro J.M., Hoen B., Cabell C.H., Abrutyn E., Rubinstein E., et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293 24 (2005) 3012-3021
10. Fowler Jr. V.G., Olsen M.K., Corey G.R., Woods C.W., Cabell C.H., Reller L.B., et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163 17 (2003) 2066-2072
11. Fowler Jr. V.G., Sanders L.L., Sexton D.J., Kong L., Marr K.A., Gopal A.K., et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 27 3 (1998) 478-486
12. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137 10 (2002) 791-797
13. Harbarth S., Rutschmann O., Sudre P., and Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 158 2 (1998) 182-189
14. Hawkins C., Huang J., Jin N., Noskin G.A., Zembower T.R., and Bolon M. Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes. Arch Intern Med 167 17 (2007) 1861-1867
15. Hill P.C., Birch M., Chambers S., Drinkovic D., Ellis-Pegler R.B., Everts R., et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J 31 2 (2001) 97-103
16. McCabe W.R., and Jackson G.G. Gram-negative bacteremia. Arch Intern Med 110 (1962) 83-91
17. Jenkins T.C., Price C.S., Sabel A.L., Mehler P.S., and Burman W.J. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 46 7 (2008) 1000-1008
18. Jensen A.G., Wachmann C.H., Espersen F., Scheibel J., Skinhoj P., and Frimodt-Moller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 162 1 (2002) 25-32
19. Johnson L.B., Almoujahed M.O., Ilg K., Maolood L., and Khatib R. Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse. Scand J Infect Dis 35 11-12 (2003) 782-789
20. Kaech C., Elzi L., Sendi P., Frei R., Laifer G., Bassetti S., et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect 12 4 (2006) 345-352
21. Khatib R., Johnson L.B., Fakih M.G., Riederer K., Khosrovaneh A., Shamse T.M., et al. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome. Scand J Infect Dis 38 1 (2006) 7-14
22. Laupland K.B., Ross T., and Gregson D.B. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 198 3 (2008) 336-343
23. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler Jr. V.G., Ryan T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 4 (2000) 633-638
24. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 339 8 (1998) 520-532
25. Mylotte J.M., Aeschlimann J.R., and Rotella D.L. Staphylococcus aureus bacteremia: factors predicting hospital mortality. Infect Control Hosp Epidemiol 17 3 (1996) 165-168
26. Mylotte J.M., and Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 31 5 (2000) 1170-1174
27. Romero-Vivas J., Rubio M., Fernandez C., and Picazo J.J. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 21 6 (1995) 1417-1423
28. Seifert H., Wisplinghoff H., Kaasch A., Achilles K., Langhorst A., Peyerl-Hoffmann G., et al. Epidemiology, course and prognosis of Staphylococcus aureus bacteremia-Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort. Dtsch Med Wochenschr 133 8 (2008) 340-345
29. Soriano A., Martinez J.A., Mensa J., Marco F., Almela M., Moreno-Martinez A., et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 30 2 (2000) 368-373
30. Tiemersma E.W., Monnet D.L., Bruinsma N., Skov R., Monen J.C., and Grundmann H. Staphylococcus aureus bacteremia, Europe. Emerg Infect Dis 11 11 (2005) 1798-1799
31. Wang J.L., Chen S.Y., Wang J.T., Wu G.H., Chiang W.C., Hsueh P.R., et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 46 6 (2008) 799-806
32. Wyllie D.H., Crook D.W., and Peto T.E. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 333 7562 (2006) 281